Journal of Vascular Surgery
Volume 45, Issue 3 , Pages 475-480 , March 2007

The role of human leukocyte antigen genes in the formation of abdominal aortic aneurysms

  • Stephen A. Badger, MB, MRCS

      Affiliations

    • Vascular and Endovascular Surgery Centre, Belfast City Hospital, Belfast, United Kingdom
    • Corresponding Author InformationReprint requests: Mr S. Badger, Vascular Research Fellow, Belfast City Hospital, Lisburn Rd, Belfast BT9 7AB, UK.
    • ,
  • Chee V. Soong, MD, FRCS

      Affiliations

    • Vascular and Endovascular Surgery Centre, Belfast City Hospital, Belfast, United Kingdom
    • ,
  • Mark E. O’Donnell, MRCS

      Affiliations

    • Vascular and Endovascular Surgery Centre, Belfast City Hospital, Belfast, United Kingdom
    • ,
  • Derek Middleton, PhD, DSc

      Affiliations

    • Histocompatability and Immunogenetics Laboratory, Belfast City Hospital, Belfast, United Kingdom.

Received 21 July 2006 ,Accepted 19 September 2006.

References 

  1. Glasgov S. Pathology of large arteries. In:  Abramson DI,  Dobrin PB editor. Blood vessels and lymphatics in organ systems. New York, NY: Academic Press; 1984;p. 39–53
  2. Dobrin P. Pathophysiology and pathogenesis of aortic aneurysms. Surg Clin North Am. 1989;69:687–703
  3. Schonbeck U, Sukhova GK, Gerdes N, Libby P. T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm. Am J Pathol. 2002;161:499–506
  4. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest. 1995;96:2304–2310
  5. Curci JA, Thompson RW. Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context?. J Clin Invest. 2004;114:168–171
  6. Clifton MA. Familial abdominal aortic aneurysms. Br J Surg. 1977;64:765–766
  7. Juvonen J, Surcel HM, Satta J, Teppo AM, Bloigu A, Syrjala H, et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1997;17:2843–2847
  8. Jones G, Brull DJ, Brown LC, Sian M, Greenhalgh RM, Humphries SE, et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation. 2001;103:2260–2265
  9. Bown MJ, Burton PR, Horsburgh T, Nicholson ML, Bell PR, Sayers RD. The role of cytokine gene polymorphisms in the pathogenesis of abdominal aortic aneurysms: a case-control study. J Vasc Surg. 2003;37:999–1005
  10. Armstrong PJ, Johanning JM, Calton WC, Delatore JR, Franklin DP, Han DC, et al. Differential gene expression in human abdominal aorta: aneurysmal versus occlusive disease. J Vasc Surg. 2002;35:346–355
  11. Pereira L, Lee SY, Gayraud B, Andrikopoulos K, Shapiro SD, Bunton T, et al. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci USA. 1999;96:3819–3823
  12. Pereira L, Andrikopoulos K, Tian J, Lee SY, Keene DR, Ono R, et al. Targeting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfans syndrome. Nat Genet. 1997;17:218–222
  13. Towbin JA, Casey B, Belmont J. The molecular basis of vascular disorders. Am J Hum Genet. 1999;64:678–684
  14. Strauss E, Waliszewski K, Gabriel M, Zapalski S, Pawlak AL. Increased risk of the abdominal aortic aneurysm in carriers of the MTHFR 677T allele. J Appl Genet. 2003;44:85–93
  15. Yen HC, Lee FY, Chau LY. Analysis of the T cell receptor V beta repertoire in human aortic aneurysms. Atherosclerosis. 1997;135:65–71
  16. Ocana E, Bohorquez JC, Perez-Requena J, Brieva JA, Rodriguez C. Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. Atherosclerosis. 2003;170:39–48
  17. Koch AE, Haines GK, Rizzo RJ, Radsevich JA, Pope RM, Robinson PG, et al. Human abdominal aortic aneurysms: immunophenotypical analysis suggesting an immune mediated process. Am J Pathol. 1990;137:1199–1219
  18. Brophy CM, Reilly JM, Walker Smith GJ, Tilson MD. The role of inflammation in non-specific abdominal aortic aneurysm disease. Ann Vasc Surg. 1991;5:229–233
  19. Beckman EN. Plasma cells infiltrates in abdominal aortic aneurysms. Am J Clin Pathol. 1986;85:21–24
  20. Haug ES, Skomsvoll JF, Jacobsen G, Halvorsen TB, Saether OD, Mythre HO. Inflammatory aortic aneurysm is associated with increased incidence of autoimmune disease. J Vasc Surg. 2003;38:492–497
  21. Newman KM, Jean-Claude J, Li H, Ramey WG, Tilson MD. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation. 1994;90:224–227
  22. Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, et al. Nomenclature for factors of the 2HLA system. Tissue Antigens. 1995;46:1–18
  23. Tilson MD, Ozsvath KJ, Hirose H, Xia S. A genetic basis for autoimmune manifestations in the abdominal aortic aneurysm residues in the MHC class 2 locus DR B-1. Ann N Y Acad Sci. 1996;800:208–215
  24. Hirose H, Takagi M, Miyagawa N, Hashiyada H, Noguchi M, Tada S, et al. Genetic risk factor for abdominal aortic aneurysm: HLA-DR2(15), a Japanese study. J Vasc Surg. 1998;27:500–503
  25. Hirose H, Tilson MD. Negative genetic risk factor for abdominal aortic aneurysm: HLA-DQ3, a Japanese study. J Vasc Surg. 1999;11:959–960
  26. Williams F, Meenagh A, Maxwell P, Middleton D. Allele resolution of HLA-A using oligonucleotide probes in a two-stage typing strategy. Tissue Antigens. 1999;54:59–68
  27. Middleton D, Williams F, Hamill MA, Meenagh A. Frequency of HLA-B alleles in a Caucasoid population determined by a two-stage PCR-SSOP typing strategy. Hum Immunol. 2000;61:1285–1297
  28. Williams F, Meenagh A, Single R, McNally M, Kelly P, Nelson MP, et al. High resolution HLA-DRB1 identification of a Caucasian population. Hum Immunol. 2004;65:66–77
  29. UK Small Aneurysm Trial participants. Mortality results for randomised controlled trial of early surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet. 1998;352:1649–1655
  30. Numano F. Differences in clinical presentation and outcome in different countries for Takayasu arteritis. Curr Opin Rheumatol. 1997;9:12–15
  31. Numano F, Kobayashi Y, Maruyama Y, Kakuta T, Miyata T, Kishi Y. Takayasu arteritis: Clinical characteristics and the role of genetic factors in its pathogenesis. Vasc Med. 1996;1:227–233
  32. Numano F, Ishohisa I, Maezawa H, Sasazuki T. HLA-antigens in Takayasu disease. Am Heart J. 1979;98:153–159
  33. Numano F, Sasazuki T, Koyama T, Shimokado K, Takeda Y, Nishimura Y, et al. HLA in Buerger disease. Exp Clin Immunogenet. 1986;3:195–200
  34. Dong PP, Kimura A, Numaro F. HLA-linked susceptibility and resistance to Takayasu arteritis. Heart Vessels. 1992;7(suppl):s73–s80
  35. Mizuki N, Inoko H, Ishihara M, Ando II, Nakamura S, Nishio M, et al. A complete type patient with Behcet’s disease associated with HLA B*5102. Acta Ophthalmol (Copenh). 1994;72:757–758
  36. Kothari SS. Aetiopathogenesis of Takatasu’s arteritis and BCG vaccination: the missing link?. Med Hypotheses. 1995;43:227–230
  37. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. The HLA-DRB1 locus as a genetic component in giant cell arteritis. J Clin Inv. 1992;90:2355–2361
  38. Ozsvath KJ, Hirose H, Xia S, Tilson MD. Molecular mimicry in human aortic aneurysmal disease. Ann N Y Acad Sci. 1996;800:288–293
  39. Xia S, Ozsvath H, Hirose H, Tilson MD. Partial amino acid sequence of a novel 40 kDa human aortic protein, with vitronectin-like, fibrinogen-like, and calcium binding domains: aortic aneurysm-associated protein-40 (AAAP-40) [Human MAGP-3, proposed]. Biochem Biophys Res Commun. 1996;219:36–39
  40. Kobayashi R, Muzutani A, Hidaka H. Isolation and characterisation of a 36 kDa microfibril associated glycoprotein by a newly synthesised isoquinoline-sulfonamide affinity chromatography. Biochem Biophys Res Commun. 1994;198:1262–1266
  41. Chew DK, Knoetgen J, Xia S, Gaetz HP, Tilson MD. Regional distribution in human of a novel aortic collagen-associated microfibrillar protein. Exp Mol Pathol. 1999;66:59–65
  42. Rasmussen TE, Hallett JW, Metzger RLM, Richardson DM, Harmsen WS, Goronzy JJ, et al. Genetic risk factors in inflammatory abdominal aortic aneurysms: polymorphic residue 70 in the HLA-DR B1 gene as a key genetic element. J Vasc Surg. 1997;25:356–364
  43. Rasmussen TE, Hallett JW, Schulte S, Harmsen WS, O’Fallon WM, Weyand CM. Genetic similarity in inflammatory and degenerative abdominal aortic aneurysms: a study of human leukocyte antigen class II disease risk genes. J Vasc Surg. 2001;34:84–89
  44. Rasmussen TE, Hallett JW, Tazelaar HD, Miller VM, Schulte S, O’Fallon WM, et al. Human leukocyte antigen class II immune response genes, female gender, and cigarette smoking as risk and modulating factors in abdominal aortic aneurysms. J Vasc Surg. 2002;35:988–993
  45. Monux G, Serrano FJ, Vigil P, de la Concha EG. Role of HLA-DR in the pathogenesis of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2003;26:211–214
  46. Tilson MD, Ozsvath KJ, Hirose H, Xia S. A genetic basis for autoimmune manifestations in the abdominal aortic aneurysm resides in the MHC class II locus DR-beta-1. Ann N Y Acad Sci. 1996;800:208–217
  47. Weyand CM, Grononzy JJ. Functional domains on HLA-DR molecules: implications for the linkage of HLA-DR genes to different autoimmune disease. Clin Immunol Immunopathol. 1994;70:91–98
  48. Sugimoto T, Sada M, Miyanoto T, Yao H. Genetic analysis on HLA loci in Japanese patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2003;26:215–218

 Competition of interest: none.

PII: S0741-5214(07)00021-3

doi: 10.1016/j.jvs.2006.09.067

Journal of Vascular Surgery
Volume 45, Issue 3 , Pages 475-480 , March 2007

Article Tools

* Image Usage & Resolution